Inspire Investing LLC Sells 614 Shares of Encompass Health Co. (NYSE:EHC)

Inspire Investing LLC lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 32,396 shares of the company’s stock after selling 614 shares during the quarter. Inspire Investing LLC’s holdings in Encompass Health were worth $2,992,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. UMB Bank n.a. raised its position in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the last quarter. Avior Wealth Management LLC purchased a new stake in shares of Encompass Health in the 3rd quarter worth $40,000. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after purchasing an additional 198 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Down 1.4 %

EHC opened at $94.47 on Thursday. The stock has a 50-day moving average of $96.92 and a 200 day moving average of $94.19. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12 month low of $69.95 and a 12 month high of $104.55. The firm has a market cap of $9.52 billion, a P/E ratio of 22.82, a P/E/G ratio of 1.14 and a beta of 0.89.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the firm posted $0.86 EPS. Encompass Health’s quarterly revenue was up 11.9% compared to the same quarter last year. As a group, research analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. UBS Group increased their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial reissued a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.